DNA Script Expands Series B to $89M

Funding & investments

Home » Funding & investments

Berkeley Lights Announces Pricing of Initial Public Offering

EMERYVILLE, Calif., July 16, 2020 (GLOBE NEWSWIRE) — Berkeley Lights, Inc., a leader in Digital Cell Biology, today announced the pricing of its initial public offering of 8,100,000 shares of common stock at a...

SAB Biotherapeutics Closes Series B Funding

Glympse Bio Announces $46.7 Million Series B Financing

Proceeds Support PMA-Enabling Study of Glympse Technology in NASH Patients CAMBRIDGE, Mass., July 15, 2020 /PRNewswire/ — Glympse Bio (Glympse), a biotechnology company advancing the way diseases are understood...

James Currier

As Some Startup VCs Hunker Down, Others Are Finding New Ways To Fund The Next AWS Of Biology

Telum Therapeutics raises € 4.1 million in its first round of financing to advance the development of new synthetic biology-based therapies for the treatment of infectious diseases caused by multi-resistant bacteria.

CARB-X funds Eligo Bioscience to develop CRISPR-based therapeutics derived from bacteriophages to kill superbugs and prevent deadly infections in transplant patients

Neoleukin Therapeutics Announces Pricing of $76.2 Million Public Offering

Boost Biomes announces close of Series A and co-development agreement with lead investor, Yara International, for biostimulants products

Amyris Raises $200 Million From Private Placement

Intellia Therapeutics Announces Closing of $115 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Tropic Biosciences raises $28.5 million Series B financing to transform the massive tropical agriculture industry

bioeconomy

New McKinsey Report Sees A $4 Trillion Gold Rush In This One Hot Sector. Who’s Selling Picks And Shovels?

Ginkgo Bioworks

Ginkgo Bioworks to Build Infrastructure for Rapid Epidemic Response with $70MM Investment

Octant

Octant Launches Polypharmacology Drug Discovery Engine for Complex Diseases with $30 Million Series A Financing Led by Andreessen Horowitz

GRAIL Announces $390 Million Series D Financing